Literature DB >> 30225389

Revisiting the prognostic relevance of muscle mass among non-metastatic colorectal cancer.

Omar Abdel-Rahman1,2, Winson Y Cheung2.   

Abstract

Entities:  

Year:  2018        PMID： 30225389      PMCID： PMC6131352          DOI： 10.21037/tgh.2018.07.11

Source DB:  PubMed          Journal:  Transl Gastroenterol Hepatol        ISSN： 2415-1289


× No keyword cloud information.
  14 in total

1.  Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  R Labianca; B Nordlinger; G D Beretta; S Mosconi; M Mandalà; A Cervantes; D Arnold
Journal:  Ann Oncol       Date:  2013-10       Impact factor: 32.976

2.  Skeletal muscle density predicts prognosis in patients with metastatic renal cell carcinoma treated with targeted therapies.

Authors:  Sami Antoun; Emilie Lanoy; Roberto Iacovelli; Laurence Albiges-Sauvin; Yohann Loriot; Mansouriah Merad-Taoufik; Karim Fizazi; Mario di Palma; Vickie E Baracos; Bernard Escudier
Journal:  Cancer       Date:  2013-06-25       Impact factor: 6.860

3.  Revisiting Dukes' paradigm; some node positive colon cancer patients have better prognosis than some node negative patients.

Authors:  O Abdel-Rahman
Journal:  Clin Transl Oncol       Date:  2017-10-30       Impact factor: 3.405

4.  Muscle radiodensity and mortality in patients with colorectal cancer.

Authors:  Candyce H Kroenke; Carla M Prado; Jeffrey A Meyerhardt; Erin K Weltzien; Jingjie Xiao; Elizabeth M Cespedes Feliciano; Bette J Caan
Journal:  Cancer       Date:  2018-05-24       Impact factor: 6.860

Review 5.  Do the differences between the amino acid compositions of acute-phase and muscle proteins have a bearing on nitrogen loss in traumatic states?

Authors:  P J Reeds; C R Fjeld; F Jahoor
Journal:  J Nutr       Date:  1994-06       Impact factor: 4.798

6.  Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.

Authors:  Adriana Villaseñor; Rachel Ballard-Barbash; Kathy Baumgartner; Richard Baumgartner; Leslie Bernstein; Anne McTiernan; Marian L Neuhouser
Journal:  J Cancer Surviv       Date:  2012-10-04       Impact factor: 4.442

7.  Impact of Weight Changes After the Diagnosis of Stage III Colon Cancer on Survival Outcomes.

Authors:  Joanna Vergidis; Gillian Gresham; Howard J Lim; Daniel J Renouf; Hagen F Kennecke; Jenny Y Ruan; Jennifer T Chang; Winson Y Cheung
Journal:  Clin Colorectal Cancer       Date:  2015-07-26       Impact factor: 4.481

8.  Colorectal cancer treatment in older patients.

Authors:  Hanna K Sanoff; Richard M Goldberg
Journal:  Gastrointest Cancer Res       Date:  2007-11

9.  Body mass index and body surface area and their associations with outcomes in stage II and III colon cancer.

Authors:  Sina Alipour; Hagen F Kennecke; Ryan Woods; Howard J Lim; Caroline Speers; Carl J Brown; Sharlene Gill; Daniel J Renouf; Winson Y Cheung
Journal:  J Gastrointest Cancer       Date:  2013-06

10.  The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS).

Authors:  Justin C Brown; Bette J Caan; Jeffrey A Meyerhardt; Erin Weltzien; Jingjie Xiao; Elizabeth M Cespedes Feliciano; Candyce H Kroenke; Adrienne Castillo; Marilyn L Kwan; Carla M Prado
Journal:  J Cachexia Sarcopenia Muscle       Date:  2018-05-15       Impact factor: 12.910
View more
  1 in total

1.  Prognostic impact of myosteatosis in patients with colorectal cancer: a systematic review and meta-analysis.

Authors:  Chan Mi Lee; Jeonghyun Kang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2020-06-01       Impact factor: 12.910
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.